2025 North America Blood Testing Market Revenue Opportunities Report
Description
The 2025 North America Blood Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the North American blood testing market are Labcorp, Quest Diagnostics, Abbott Laboratories, and Roche Diagnostics. Labcorp, headquartered in Burlington, North Carolina, operates a vast clinical laboratory network with over 2,000 patient service centers and performs more than 160 million tests annually, including genomic and specialty testing. Quest Diagnostics holds the largest market share in US diagnostic and medical laboratories, providing comprehensive pathology and clinical testing services nationwide. Abbott Laboratories, based in Illinois, offers advanced diagnostics, including rapid COVID-19 tests and continuous glucose monitoring, and operates in over 160 countries. Roche Diagnostics leads with innovations in high-sensitivity assays and recently gained FDA Breakthrough Device Designation for cardiovascular-related testing.
These companies dominate due to their extensive service networks, technological innovations, and strategic acquisitions. Labcorp supports drug development and diagnostic services widely utilized in pharmaceutical research. Quest Diagnostics is noted for its broad test offerings and convenient patient access points across North America. Abbott leverages rapid point-of-care and wearable diagnostic technologies to address both clinical and consumer health markets. Roche focuses on specialized, breakthrough diagnostic solutions, including oncology and cardiovascular assays, driving early disease detection and personalized care. Together, they shape the North American blood testing market through large-scale testing volumes, continuous R&D investment, and regulatory compliance.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the North American blood testing market are Labcorp, Quest Diagnostics, Abbott Laboratories, and Roche Diagnostics. Labcorp, headquartered in Burlington, North Carolina, operates a vast clinical laboratory network with over 2,000 patient service centers and performs more than 160 million tests annually, including genomic and specialty testing. Quest Diagnostics holds the largest market share in US diagnostic and medical laboratories, providing comprehensive pathology and clinical testing services nationwide. Abbott Laboratories, based in Illinois, offers advanced diagnostics, including rapid COVID-19 tests and continuous glucose monitoring, and operates in over 160 countries. Roche Diagnostics leads with innovations in high-sensitivity assays and recently gained FDA Breakthrough Device Designation for cardiovascular-related testing.
These companies dominate due to their extensive service networks, technological innovations, and strategic acquisitions. Labcorp supports drug development and diagnostic services widely utilized in pharmaceutical research. Quest Diagnostics is noted for its broad test offerings and convenient patient access points across North America. Abbott leverages rapid point-of-care and wearable diagnostic technologies to address both clinical and consumer health markets. Roche focuses on specialized, breakthrough diagnostic solutions, including oncology and cardiovascular assays, driving early disease detection and personalized care. Together, they shape the North American blood testing market through large-scale testing volumes, continuous R&D investment, and regulatory compliance.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
